ATE455846T1 - Verwendung einer zusammensetzung mit n- acetylcystein zur konditionierung von stammzellen - Google Patents

Verwendung einer zusammensetzung mit n- acetylcystein zur konditionierung von stammzellen

Info

Publication number
ATE455846T1
ATE455846T1 AT01976371T AT01976371T ATE455846T1 AT E455846 T1 ATE455846 T1 AT E455846T1 AT 01976371 T AT01976371 T AT 01976371T AT 01976371 T AT01976371 T AT 01976371T AT E455846 T1 ATE455846 T1 AT E455846T1
Authority
AT
Austria
Prior art keywords
acetylcysteine
stem cells
composition containing
conditioning
conditioning stem
Prior art date
Application number
AT01976371T
Other languages
English (en)
Inventor
Odile Cohen-Haguenauer
Original Assignee
Igr Et D
Odile Cohen-Haguenauer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igr Et D, Odile Cohen-Haguenauer filed Critical Igr Et D
Application granted granted Critical
Publication of ATE455846T1 publication Critical patent/ATE455846T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/14—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/145—Thrombopoietin [TPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
AT01976371T 2000-10-06 2001-10-05 Verwendung einer zusammensetzung mit n- acetylcystein zur konditionierung von stammzellen ATE455846T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0012845A FR2815042B1 (fr) 2000-10-06 2000-10-06 Utilisation d'une composition a activite antioxydante pour le conditionnement de cellules souches
PCT/FR2001/003087 WO2002029011A2 (fr) 2000-10-06 2001-10-05 Utilisation d"une composition a activite antioxydante pour le conditionnement de cellules souches

Publications (1)

Publication Number Publication Date
ATE455846T1 true ATE455846T1 (de) 2010-02-15

Family

ID=8855112

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01976371T ATE455846T1 (de) 2000-10-06 2001-10-05 Verwendung einer zusammensetzung mit n- acetylcystein zur konditionierung von stammzellen

Country Status (6)

Country Link
EP (1) EP1363995B1 (de)
AT (1) ATE455846T1 (de)
AU (1) AU2001295665A1 (de)
DE (1) DE60141169D1 (de)
FR (1) FR2815042B1 (de)
WO (1) WO2002029011A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003249227A1 (en) 2002-07-12 2004-02-02 University Of Washington Methods and systems for extended in vitro culture of neuronal cells
JPWO2005121320A1 (ja) * 2004-06-10 2008-04-10 協和醗酵工業株式会社 幹細胞自己複製促進剤
KR100679642B1 (ko) 2005-11-16 2007-02-06 주식회사 알앤엘바이오 인간 지방조직 유래 다분화능 줄기세포 및 이를 함유하는세포치료제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2114817B1 (es) * 1996-05-16 1999-02-16 Zambon S A Asociacion farmacologica entre n-acetilcisteina y levulosa para la prevencion de la muerte celular y enfermedades asociadas.
AU3888699A (en) * 1998-05-07 1999-11-23 University Of South Florida Bone marrow cells as a source of neurons for brain and spinal cord repair
JP3291698B2 (ja) * 1998-07-24 2002-06-10 スティーブン・カーティン 可変眼鏡用レンズ

Also Published As

Publication number Publication date
FR2815042A1 (fr) 2002-04-12
WO2002029011A2 (fr) 2002-04-11
AU2001295665A1 (en) 2002-04-15
EP1363995A2 (de) 2003-11-26
FR2815042B1 (fr) 2005-01-07
EP1363995B1 (de) 2010-01-20
DE60141169D1 (de) 2010-03-11
WO2002029011A3 (fr) 2002-07-18

Similar Documents

Publication Publication Date Title
CY1107778T1 (el) Ανθρωπινα cd45+ ή/και ινοβλαστης + μεσεγχυματικα βλαστικα κυτταρα
ATE238024T1 (de) Zusammensetzung zur verzögerung des haarwuchses und entsprechende verwendung
DE60137096D1 (de) Zusammensetzung zur Unterbindung von Körpergeruch und Verwendung derselben
TR200102308T2 (tr) Yüzey etkinliğine sahip yapay peptidler ve bunların yapay yüzey aktif maddelerin hazırlanmasında kullanımı
AU144678S (en) Bottle
ATE311762T1 (de) Verwendung von säurestabilen subtilisinproteasen in tierfutter
BR9709418B1 (pt) composição não terapêutica compreendendo creatina para consumo humano.
TW200706189A (en) Porous implant
AU303674S (en) Scissors
AU303737S (en) Writing instrument and cap
AU4584901A (en) Structural modification of 19-norprogesterone i: 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
ATE424461T1 (de) Modifizierte zytokine für krebs therapie
FR2749022B1 (fr) Cellules aviaires immortelles
ES2188261T3 (es) Tiomolibdato asociado a, al menos, un hidrato de carbono y su uso en la prevencion o tratamiento de enfermedades caracterizadas por una vacularizacion aberrante, tales como cancer, degeneracion macular tipo humedo, artritis reumatoides.
AU306090S (en) Scissors
AU2002364302A1 (en) Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases
BR9900559A (pt) Composição de vidro de tipo sìlico-sodo-cálcico.
ATE455846T1 (de) Verwendung einer zusammensetzung mit n- acetylcystein zur konditionierung von stammzellen
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
TW200704407A (en) Composition and method for promoting hair growth
EP1404350A4 (de) Mit zellwachstum, zelldifferenzierung und zelltod assoziierten proteinen
EP0932337A4 (de) Vitrifizierungslösungen zur langfristigen aufbewahrung von zellen, geweben, organen und organismen
AU5780999A (en) Genes that regulate hematopoietic blood forming stem cells and uses thereof
GB9723824D0 (en) Cytostatic agents
ATE248781T1 (de) Glaspulver und dessen verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties